Moderna Reports Q1 2026 Earnings with Revenue Growth and Litigation Settlement
Moderna (MRNA) reported Q1 2026 earnings with total revenue of $400 million, up $300 million year-over-year, but faced a net loss of $1.3 billion due to a $878 million litigation settlement charge. The company also announced a $950 million lump sum payment to be made in Q3 2026, with potential additional contingent payments.
Tickers: $MRNA
Topics: Cash Reserves Earnings Litigation Settlement Net Loss R&D Expenses Revenue